Core Laboratories (NYSE:CLB) Releases Earnings Results, Beats Expectations By $0.03 EPS

Core Laboratories (NYSE:CLB) issued its earnings results on Wednesday. The oil and gas company reported $0.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.03, FiscalAI reports. Core Laboratories had a net margin of 5.10% and a return on equity of 10.06%. The company had revenue of $124.61 million for the quarter, compared to analysts’ expectations of $126.26 million. During the same period in the prior year, the firm earned $0.19 EPS. Core Laboratories’s quarterly revenue was down 4.3% compared to the same quarter last year. Core Laboratories updated its Q3 2026 guidance to 0.120-0.200 EPS.

Core Laboratories Stock Performance

Shares of NYSE CLB traded up $0.53 during trading hours on Friday, reaching $10.88. 223,497 shares of the stock were exchanged, compared to its average volume of 590,879. The firm has a market capitalization of $501.57 million, a price-to-earnings ratio of 19.23, a P/E/G ratio of 2.38 and a beta of 1.00. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.50 and a current ratio of 2.05. Core Laboratories has a 52 week low of $9.72 and a 52 week high of $20.36. The stock’s fifty day simple moving average is $12.08 and its 200 day simple moving average is $15.26.

Core Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Monday, August 10th will be given a $0.01 dividend. The ex-dividend date of this dividend is Monday, August 10th. This represents a $0.04 annualized dividend and a dividend yield of 0.4%. Core Laboratories’s dividend payout ratio is presently 6.15%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Aster Capital Management DIFC Ltd acquired a new stake in shares of Core Laboratories during the fourth quarter worth $34,000. Quarry LP grew its stake in shares of Core Laboratories by 118.1% in the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after acquiring an additional 1,599 shares in the last quarter. Tower Research Capital LLC TRC grew its stake in shares of Core Laboratories by 400.9% in the second quarter. Tower Research Capital LLC TRC now owns 7,333 shares of the oil and gas company’s stock valued at $84,000 after acquiring an additional 5,869 shares in the last quarter. Vestcor Inc bought a new position in Core Laboratories during the third quarter worth about $101,000. Finally, Mercer Global Advisors Inc. ADV bought a new position in Core Laboratories during the third quarter worth about $132,000. 97.81% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

CLB has been the topic of a number of recent analyst reports. Wall Street Zen downgraded Core Laboratories from a “hold” rating to a “sell” rating in a research report on Saturday, July 4th. Weiss Ratings downgraded Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, June 24th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Core Laboratories currently has an average rating of “Reduce”.

Key Headlines Impacting Core Laboratories

Here are the key news stories impacting Core Laboratories this week:

• Positive Sentiment: Core Lab reported adjusted Q2 EPS of $0.11, above the $0.08 analyst consensus. Earnings improved 85% sequentially, helped by strength in the Production Enhancement business. Core Laboratories Q2 Earnings Beat Estimates, Decline Y/Y
• Positive Sentiment: Revenue rose 2% sequentially to $124.6 million, while operating income excluding special items increased 42% sequentially to $9.4 million. The company also generated $3.1 million in free cash flow and repurchased approximately 215,000 shares for $2.7 million. Core Lab Reports Second Quarter 2026 Results
• Positive Sentiment: Management’s earnings call pointed to a gradual recovery, potentially supporting investor confidence if improving activity leads to stronger future demand for Core Lab’s reservoir and production services. Core Laboratories Earnings Call Signals Gradual Recovery
• Neutral Sentiment: Core Lab declared a $0.01-per-share quarterly dividend, payable August 31 to shareholders of record August 10. The dividend provides modest shareholder income, with an annualized yield of approximately 0.4%.
• Negative Sentiment: Q2 revenue of $124.6 million fell short of the $126.3 million consensus and declined 4.3% year over year. Adjusted EPS also dropped from $0.19 a year earlier to $0.11, reflecting continued operating pressure, particularly in Reservoir Description. Core Laboratories Q2 Earnings Report
• Negative Sentiment: Third-quarter EPS guidance of $0.12–$0.20 has a midpoint of $0.16, slightly below the $0.17 analyst estimate. Revenue guidance of $128.5 million–$135.5 million is broadly in line with expectations, but the wide range signals uncertainty. Core Lab Third-Quarter Guidance

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.